Bedfont® Scientific is celebrating the 30th anniversary of its Smokerlyzer® breath carbon monoxide (CO) monitor with a prize draw competition and three chances to win their gold-standard Micro+ Smokerlyzer®.

Bedfont Scientific, based in Harrietsham, Kent, has specialised in breath analysis since 1976 and is this year celebrating the 30th anniversary of its esteemed Smokerlyzer® breath CO monitor. In honour of the Smokerlyzer’s® 30th birthday, Bedfont are giving 3 lucky winners the chance to win one of their gold standard Micro+ Smokerlyzer®, which currently retails for around £300. The competition features a newspaper cut-out from 1986 with a National Treasure demonstrating an earlier Smokerlyzer®.

The Smokerlyzer® range is a series of carbon monoxide (CO) monitors that measures the harmful amount of CO that is inhaled from smoking, which can show how much a patient has been smoking, giving smoking cessation advisors an idea on the level of dependency that the smoker has. The Smokerlyzer® is quick, non-invasive and also acts as a motivational visual aid to encourage the user to quit smoking and to measure their progress whilst doing so.

But what makes the Micro+ the top end product is its ability to store patient data to create profiles and create a graphical track of a smokers’ quit attempt, in addition to the ability to monitor foetal carbon monoxide for pregnant smokers, and also ambient carbon monoxide to check pollution levels and external factors that might contribute to a higher than normal CO reading.

Jason Smith, General Manager at Bedfont Scientific, says,

“The Smokerlyzer ® is world renown; it has been demonstrated by the likes of Princess Diana, Sir Alex Ferguson and more recently featured on BBC2’s show Horizon on E-Cigarettes, it has contributed to several clinical papers and has saved countless lives in the past 30 years. Running the competition gives us a way to celebrate this success with our customers. Looking back at the timeline, the Smokerlyzer ® has come such a long way and I couldn’t be more proud.”

To enter the competition, please visit www.bedfont.com/30yearsofsmokerlyzer

Bedfont® Scientific is celebrating the 30th anniversary of its Smokerlyzer® at this year’s conference and will be offering the opportunity for UKNSCC attendees to walk away with a free iPad.

This year Bedfont’s representative Intermedical will be at the UKNSCC, an essential event for everyone working in the smoking cessation and tobacco control fields. To celebrate 30 years of Smokerlyzer® this year, Bedfont and Intermedical are giving the lucky attendants of the UKNSCC the chance to win a brand new iPad mini as well as a variety of instant prizes on the stand.

Bedfont Scientific, based in Harrietsham, Kent, has specialised in breath analysis for 40 years and has a worldwide network of distributors. Bedfont has been working with its sole Smokerlyzer® distributor, Intermedical, in the UK for five years and are proud to be representing Bedfont at this show.

Michael Collyer, Marketing Manager at Intermedical, says,

“We are proud to be a representative of a longstanding UK company like Bedfont Scientific and are honoured to partake in the 30 years of Smokerlyzer® celebrations. Since 2011 we have sold over 30,000 Smokerlyzers® in the UK and it’s become an essential tool in Stop Smoking Services.”

The Smokerlyzer® range is a series of carbon monoxide (CO) monitors that measures the harmful amount of CO that is inhaled from smoking, which can show how much a patient has been smoking, giving smoking cessation advisors an idea on the level of dependency that the smoker has. The Smokerlyzer® is quick, non-invasive and also acts as a motivational visual aid to encourage the user to quit smoking and to measure their progress whilst doing so.

Jason Smith, General Manager at Bedfont Scientific, says,

“Smokerlyzer® has contributed to peoples’ health and has saved countless lives in the past 30 years. Running the competition with Intermedical gives us a way to celebrate its success with our customers. Looking back at the timeline, the Smokerlyzer® has come such a long way and I couldn’t be more proud.”

Bedfont® Scientific manufactures the Gastrolyzer range of breath analysis monitors which helps dietitians detect and treat dietary problems and breath testing represents an innovative leap in medical technology.

This year Dietitian Week takes place between 6-10 June, marking the 3rd annual awareness week for Dietitians. Established by the British Dietetic Association (BDA), the week’s aim is to highlight the work and worth of dietitians and the impact of the dietetic profession in the UK. Registered Dietitians are the only qualified health professionals that assess, diagnose and treat dietary problems. Diagnosis can be done swiftly and with ease thanks to the Gastrolyzer range of breath hydrogen/methane monitors, produced by Bedfont Scientific, based in Kent.

By measuring the amount of hydrogen and/or methane in a patient’s breath that is caused by the breakdown of food in the gut, the Gastrolyzer investigates if a patient has any sugar-related food intolerances such lactose intolerance and can also be used to help detect other gastrointestinal disorders such as SIBO and IBS.  Unlike more conventional methods which can take up to two weeks to diagnose, the simple breath test does not require a blood sample and provides instant results. Additionally, the new protocol option allows Dietitians to test multiple patients at once, saving valuable time.

Louise Gankerseer-Hodgson, Head of Dietetics at London Bridge Hospital, explains,

“Hydrogen and methane measures are useful, helping to contribute to our patients’ assessments and therefore tailored therapies”.

One patient, who received a Gastrolyzer breath test at London Bridge Hospital, added,

“I found the breath testing procedure very useful. The machine and home-kit equipment allowed me to measure what food groups had been affecting my day-to-day life. I found it a very straightforward test and the procedure ran smoothly.”

Bedfont Scientific, based in Maidstone, Kent, donates over 50 Smokerlyzers® to the European Network for Smoking and Tobacco Prevention (ENSP)

Bedfont Scientific, who in 2016 is celebrating 40 years in business, has donated over 50 carbon monoxide breath monitors, famously known as the Smokerlyzer®, to the ENSP. Bedfont hopes to help them establish carbon monoxide (CO) verification into European Stop Smoking Services (SSS) to motivate people to stop smoking. This decision arrives after success with CO monitoring in Smoking Cessation in the UK, following the publication of the NICE guidelines for Stop Smoking Services in February 2008.

On the 5-6th April 2016, the ENSP, held its hands-on training programme of the Global Bridges grant entitled “European Accreditation Curriculum on Tobacco Treatment”. Funded through a Pfizer Independent Grant for Learning and Change through Global Bridges, this capacity development project aimed to train and certify (with the provision of CME) professionals on treating tobacco dependency in Eastern Europe with a particular focus on clinicians from Romania, Armenia, Georgia, Ukraine and Russia.

Over 190 participants from around the globe participated in an interactive programme, which included keynote presentations from the head of the WHO FCTC secretariat and the head of the Tobacco Unit of the European Commission-DG SANTE among a number of leading researchers in tobacco control and treatment.  

Dominick Nguyen, Health Policy and Communication Manager at ENSP, says,

“The training programme received great enthusiasm from clinicians, health professionals, researchers and KOLs from Eastern Europe, who had the chance to discover and practice carbon monoxide measurements with the Smokerlyzers. Participants really appreciated receiving a CO monitor as part of their training, and looked forward to start using it on their patients.”

Jason Smith, General Manager at Bedfont Scientific, comments,

“Bedfont is honoured to play a key part in the new movements in Eastern Europe against tobacco dependency. With 30 years on its side, we hope that the Smokerlyzer proves to be as invaluable and effective at helping people quit smoking in Eastern Europe as it has been here in the UK and in our other larger markets.”

Photos for the event can be found here.

Bedfont® incorporates SteriTouch® technology into the redesign of its famous monitors

Bedfont Scientific, who in 2016 are celebrating two important anniversaries – 40 years in business and 30 years of one of their most successful exports – the Smokerlyzer, are revered as pioneers in the breath analysis market. Their products are now available in over 76 countries across the world thanks to their unprecedented network of appointed distributors.

However, belonging to such a niche medical devices market, Bedfont Scientific is always innovating and improving their monitors to remain the market leaders in their fields. Following the success and feedback from integrating SteriTouch technology into their piCO+™ Smokerlyzer® in 2012, Bedfont decided to include antimicrobial technology in the redesign of their ranges.                

Current ranges now with SteriTouch technology include the Smokerlyzer, a carbon monoxide (CO) breath monitor used by Stop Smoking Services, the ToxCO™ used by emergency services to instantly diagnose CO poisoning, and the Gastrolyzer® for detecting gastrointestinal orders. The plan for the future is to continue to incorporate SteriTouch technology into Bedfont’s remaining ranges too. 

Jason Smith, General Manager at Bedfont Scientific, explains,

“We felt that including SteriTouch technology into all of our monitors was a simply natural progression. With all of our devices being used in medical and clinical environments, to ensure optimum performance and omit cross-infection which can affect patients’ results, SteriTouch technology seemed like the ideal extra protection for our breath monitors.”